Polymyxin-resistant clinical isolates of Escherichia coli. - Wikidata - awgldk - TriplyDB

Polymyxin-resistant clinical isolates of Escherichia coli.

Polymyxin-resistant clinical isolates of Escherichia coli.

http://www.wikidata.org/entity/Q34483666

about

A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion.Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria.Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes.Low-dose polymyxin: an option for therapy of Gram-negative sepsis.NDM-1-producing Klebsiella pneumoniae resistant to colistin in a French community patient without history of foreign travel.Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli Multicenter prospective study on the prevalence of colistin resistance in Escherichia coli: relevance of mcr-1-positive clinical isolates in Lombardy, Northern Italy.

P2860

Q34002469-42562637-DDA5-4857-ACD5-16670826ABA9 Q37014270-EF93E2A9-3344-4D30-8B31-061C7E4111FA Q37872942-36C09C6D-EFA5-42EB-A347-023AE0992808 Q37894694-135C4D1B-9C13-46A6-BE9A-ECCEEE42CE7A Q40272427-4FECB55C-FFC6-4540-8B3B-F0E9744AD5DD Q42189694-AA9033E9-1FF4-4A1D-9CFF-F7A3D10DA759 Q42190018-B3E6EE53-5412-43D2-B644-2AEFE6146AF9 Q55223006-DDA18C39-3330-4AEF-9903-856A59B9BC79

P2860

Polymyxin-resistant clinical isolates of Escherichia coli.

http://www.wikidata.org/entity/Q34483666

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Polymyxin-resistant clinical isolates of Escherichia coli.

@ast

Polymyxin-resistant clinical isolates of Escherichia coli.

@en

Polymyxin-resistant clinical isolates of Escherichia coli.

@nl

type

label

Polymyxin-resistant clinical isolates of Escherichia coli.

@ast

Polymyxin-resistant clinical isolates of Escherichia coli.

@en

Polymyxin-resistant clinical isolates of Escherichia coli.

@nl

prefLabel

Polymyxin-resistant clinical isolates of Escherichia coli.

@ast

Polymyxin-resistant clinical isolates of Escherichia coli.

@en

Polymyxin-resistant clinical isolates of Escherichia coli.

@nl

P1433

Q34483666-2FEF19E6-C17A-4DD4-A0B4-8E58E97F6501

P1476

Q34483666-4728C344-DC22-494D-9578-6C9C239B984B

P2093

Q34483666-0E5CD76B-D8B2-49D9-9E1B-90ED0D89E0F2

Q34483666-68597694-F01A-4000-AAFC-A21514A20358

Q34483666-6937B36E-C78B-496B-8808-B704863EF1DC

Q34483666-8E953637-CD26-48F2-90CC-A09AF138E0BD

Q34483666-EDC3538F-E998-406B-B3C7-B6838527FA7E

P2860

Q34483666-0E30639D-31BD-4019-A249-0222A4734F40

Q34483666-1C62E3F7-6E7A-4BD2-8FCC-B30D39C553E4

Q34483666-1DFF5268-D985-4A52-8966-0214ABDC95FB

Q34483666-21B84AD1-13F2-4769-9E8D-F077C9E40279

Q34483666-49940DF9-5287-416B-9817-333C4942B8B9

Q34483666-794D41FC-76BD-4DF3-954E-D473A5181A3E

Q34483666-85D7973B-C69F-46F6-8F65-46777F8B4936

Q34483666-87B2C4B3-9CCA-49F4-86BD-D2ACB58E70BF

Q34483666-9009276F-6CEB-4877-848F-B293CF7F2637

Q34483666-B129CD80-EC50-4C9D-AEE1-03EADE8AF76E

P304

Q34483666-DC49E90E-7EBA-4E9F-8700-2E3C2B5AFDF5

P31

Q34483666-426250C5-CC77-40AF-B5CB-C2755D4F5653

P356

Q34483666-F31A7E67-5806-4FD7-B2E7-6FA9369E166A

P407

Q34483666-4000C24B-39EB-403A-825F-F2E7994C2705

P433

Q34483666-3E0B3EDF-E10F-4FB4-B81F-5183C0E10AF9

P478

Q34483666-01B4342E-785F-46D1-B0CC-507BB02B9B5B

P577

Q34483666-E892836E-79BF-40EB-8209-1C40304BCF77

P698

Q34483666-5681BE54-B34D-430C-BB37-9578AD4D9129

P921

Q34483666-22C5A6A3-09A4-49D0-B2BF-4209FADD53D0

P932

Q34483666-875FED86-2654-4202-A93F-52DE8A379105

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Polymyxin-resistant clinical isolates of Escherichia coli.

@en

P2093

Carl Urban

http://www.w3.org/2001/XMLSchema#string

Hemavarna Tiruvury

http://www.w3.org/2001/XMLSchema#string

James J Rahal

http://www.w3.org/2001/XMLSchema#string

Noriel Mariano

http://www.w3.org/2001/XMLSchema#string

Rita Colon-Urban

http://www.w3.org/2001/XMLSchema#string

P2860

Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.

Origin of lipid A species modified with 4-amino-4-deoxy-L-arabinose in polymyxin-resistant mutants of Escherichia coli. An aminotransferase (ArnB) that generates UDP-4-deoxyl-L-arabinose.

In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008.

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.

Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities.

Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

P304

388-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01088-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21041507

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

P932

3019679

http://www.w3.org/2001/XMLSchema#string